These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

745 related items for PubMed ID: 26883911

  • 1. MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells.
    Lima CR, Geraldo MV, Fuziwara CS, Kimura ET, Santos MF.
    BMC Cancer; 2016 Feb 16; 16():108. PubMed ID: 26883911
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
    Geraldo MV, Yamashita AS, Kimura ET.
    Oncogene; 2012 Apr 12; 31(15):1910-22. PubMed ID: 21874046
    [Abstract] [Full Text] [Related]

  • 3. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
    Chou CK, Yang KD, Chou FF, Huang CC, Lan YW, Lee YF, Kang HY, Liu RT.
    J Clin Endocrinol Metab; 2013 Feb 12; 98(2):E196-205. PubMed ID: 23264400
    [Abstract] [Full Text] [Related]

  • 4. MiR-146b-5p Regulates the Expression of Long Noncoding RNA MALAT1 and Its Effect on the Invasion and Proliferation of Papillary Thyroid Cancer.
    Peng Y, Fang X, Yao H, Zhang Y, Shi J.
    Cancer Biother Radiopharm; 2021 Jun 12; 36(5):433-440. PubMed ID: 32343601
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting NF2 in Human Papillary Thyroid Cancer.
    Yu C, Zhang L, Luo D, Yan F, Liu J, Shao S, Zhao L, Jin T, Zhao J, Gao L.
    Thyroid; 2018 Dec 12; 28(12):1627-1641. PubMed ID: 30244634
    [Abstract] [Full Text] [Related]

  • 6. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D, Zheng Y.
    Endocr J; 2021 May 28; 68(5):583-597. PubMed ID: 33612561
    [Abstract] [Full Text] [Related]

  • 7. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z, Hardin H, Montemayor-Garcia C, Asioli S, Righi A, Maletta F, Sapino A, Lloyd RV.
    Endocr Pathol; 2015 May 28; 26(2):157-63. PubMed ID: 25771986
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-146b-5p as an oncomiR promotes papillary thyroid carcinoma development by targeting CCDC6.
    Jia M, Shi Y, Li Z, Lu X, Wang J.
    Cancer Lett; 2019 Feb 28; 443():145-156. PubMed ID: 30503553
    [Abstract] [Full Text] [Related]

  • 9. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.
    Liu ZM, Wu ZY, Li WH, Wang LQ, Wan JN, Zhong Y.
    Eur Rev Med Pharmacol Sci; 2019 Apr 28; 23(8):3421-3430. PubMed ID: 31081096
    [Abstract] [Full Text] [Related]

  • 10. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.
    Qiu Z, Li H, Wang J, Sun C.
    Oncol Rep; 2017 Nov 28; 38(5):2735-2740. PubMed ID: 29048684
    [Abstract] [Full Text] [Related]

  • 11. MiR-202-3p functions as a tumor suppressor and reduces cell migration and invasion in papillary thyroid carcinoma.
    Chen J, Yin J, Liu J, Zhu RX, Zheng Y, Wang XL.
    Eur Rev Med Pharmacol Sci; 2019 Feb 28; 23(3):1145-1150. PubMed ID: 30779083
    [Abstract] [Full Text] [Related]

  • 12. IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma.
    Chou CK, Chi SY, Huang CH, Chou FF, Huang CC, Liu RT, Kang HY.
    J Clin Endocrinol Metab; 2016 Nov 28; 101(11):4357-4366. PubMed ID: 27533309
    [Abstract] [Full Text] [Related]

  • 13. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor.
    Feng K, Liu Y, Xu LJ, Zhao LF, Jia CW, Xu MY.
    Biomed Pharmacother; 2018 Aug 28; 104():686-698. PubMed ID: 29803929
    [Abstract] [Full Text] [Related]

  • 14. MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3.
    Deng X, Wu B, Xiao K, Kang J, Xie J, Zhang X, Fan Y.
    Cell Physiol Biochem; 2015 Aug 28; 35(1):71-82. PubMed ID: 25547151
    [Abstract] [Full Text] [Related]

  • 15. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
    Fu S, Ma C, Tang X, Ma X, Jing G, Zhao N, Ran J.
    Biosci Rep; 2021 Sep 30; 41(9):. PubMed ID: 34486645
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
    Huang Y, Yu S, Cao S, Yin Y, Hong S, Guan H, Li Y, Xiao H.
    Thyroid; 2018 Sep 30; 28(9):1162-1173. PubMed ID: 29882471
    [Abstract] [Full Text] [Related]

  • 17. BRAFV600E and RET/PTC Promote Proliferation and Migration of Papillary Thyroid Carcinoma Cells In Vitro by Regulating Nuclear Factor-κB.
    Zhou D, Li Z, Bai X.
    Med Sci Monit; 2017 Nov 08; 23():5321-5329. PubMed ID: 29117154
    [Abstract] [Full Text] [Related]

  • 18. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
    Cazarin JM, Coelho RG, Hecht F, Andrade BM, Carvalho DP.
    Thyroid; 2016 Jul 08; 26(7):933-42. PubMed ID: 27121619
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of the human major histocompatibility complex class I chain-related gene A (MICA) and its receptor is mediated by microRNA-146b-5p and is a potential mechanism of immunoediting in papillary thyroid carcinoma.
    Al-Abdallah A, Jahanbani I, Mehdawi H, Ali RH, Al-Brahim N, Mojiminiyi O, Junaid TA.
    Exp Mol Pathol; 2020 Apr 08; 113():104379. PubMed ID: 31935378
    [Abstract] [Full Text] [Related]

  • 20. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
    Xue KC, Hu DD, Zhao L, Li N, Shen HY.
    Eur Rev Med Pharmacol Sci; 2017 Oct 08; 21(17):3794-3800. PubMed ID: 28975989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.